Erim DO, et al. - Using data from a population-based cohort of North Carolinian prostate cancer survivors, researchers analyzed patterns and predictive factors of clinical diagnosis and treatment of depression among these survivors. For self-reported clinical diagnosis of depression, the estimated average rate was 44%, which dropped from 60% to 40% between prostate cancer diagnosis and 5-7 years post-diagnosis. African American race, employment, age at enrollment, low education, infrequent primary care visits, and living with a prostate cancer diagnosis for more than 2 years were identified as factors related to lower odds of self-reported clinical diagnosis of depression. For self-reported depression treatment, the estimated average rate was 62%. Employment and living with a prostate cancer diagnosis for 2 or more years were found to be related to lower odds of self-reported depression treatment. Overall, barriers are experienced by prostate cancer survivors requiring depression care.